World Health Organization (WHO)

12 Vaccines Granted Emergency Use Listing (EUL) by WHO

• Serum Institute of India
  COVOVAX (Novavax formulation)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 6 countries

  7 trials in 3 countries

  Approval Source: extranet.who.int

  Protein Subunit

• Novavax
  Nuvaxovid

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 40 countries

  22 trials in 14 countries

  Approval Source: extranet.who.int

  Protein Subunit

• SK Bioscience Co Ltd
  SKYCovione

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  7 trials in 6 countries

  Approval Source: extranet.who.int

  Protein Subunit

• Moderna
  Spikevax

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 88 countries

  70 trials in 24 countries

  Approval Source: extranet.who.int

  RNA

• Pfizer/BioNTech
  Comirnaty

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 149 countries

  100 trials in 31 countries

  Approval Source: extranet.who.int

  RNA

• CanSino
  Convidecia

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 10 countries

  14 trials in 6 countries

  Approval Source: extranet.who.int

  Non Replicating Viral Vector

• Janssen (Johnson & Johnson)
  Jcovden

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 113 countries

  26 trials in 25 countries

  Approval Source: extranet.who.int

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  Vaxzevria

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 149 countries

  73 trials in 34 countries

  Approval Source: extranet.who.int

  Non Replicating Viral Vector

• Serum Institute of India
  Covishield (Oxford/ AstraZeneca formulation)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 49 countries

  6 trials in 1 country

  Approval Source: extranet.who.int

  Non Replicating Viral Vector

• Bharat Biotech
  Covaxin

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 14 countries

  16 trials in 2 countries

  Approval Source: extranet.who.int

  Inactivated

• Sinopharm (Beijing)
  Covilo

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 93 countries

  39 trials in 18 countries

  Approval Source: extranet.who.int

  Inactivated

• Sinovac
  CoronaVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 56 countries

  42 trials in 10 countries

  Approval Source: extranet.who.int

  Inactivated